Skip to content
Search

Latest Stories

Britain to test 100K people for Covid-19 to check spread

Britain plans to test a randomly chosen group of 100,000 people for COVID-19 as part of its efforts to understand infection rates better before loosening restrictions on the public, its health ministry said on Thursday (30).

The tests to see if people are currently infected with the respiratory disease, led by London's Imperial College and polling company Ipsos MORI, follow a separate testing programme announced last week by the University of Oxford and the Office for National Statistics.


Britain's government is due to review next week whether to relax a nationwide lockdown brought in on March 23 to slow the spread of the coronavirus, which has so far killed more than 26,000 people in Britain.

Improving capacity to track infection rates in different parts of Britain is seen by the health ministry as essential to ease restrictions safely.

Britain has suffered from limited testing capacity and Health Minister Matt Hancock promised to increase the number of tests to 100,000 a day by the end of April. On Tuesday (28), just over 52,000 tests were carried out.

The Imperial College programme will shortly contact 100,000 people across England at random and send them self-testing kits to see if they are infected.

A later part of the study will test the public's ability to self-administer antibody tests that show whether someone has had Covid-19 but is no longer infected, which may confer some immunity against the disease caused by the novel coronavirus.

So far, British officials have not found an antibody test that works reliably enough to roll out on a large scale.

(Reuters)

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less